Eisai Co Stock Short Ratio
| ESALF Stock | USD 26.00 2.50 8.77% |
Eisai Co fundamentals help investors to digest information that contributes to Eisai's financial success or failures. It also enables traders to predict the movement of Eisai Pink Sheet. The fundamental analysis module provides a way to measure Eisai's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eisai pink sheet.
Eisai |
Eisai Co Company Short Ratio Analysis
Eisai's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Eisai Co has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Eisai Fundamentals
| Return On Equity | 0.035 | |||
| Return On Asset | 0.0031 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 18.8 B | |||
| Shares Outstanding | 286.7 M | |||
| Shares Owned By Insiders | 3.43 % | |||
| Shares Owned By Institutions | 49.50 % | |||
| Price To Earning | 22.87 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 756.23 B | |||
| Gross Profit | 581.39 B | |||
| EBITDA | 96.78 B | |||
| Net Income | 47.95 B | |||
| Cash And Equivalents | 290.45 B | |||
| Total Debt | 94.89 B | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 2.06 X | |||
| Book Value Per Share | 2,699 X | |||
| Cash Flow From Operations | 117.59 B | |||
| Earnings Per Share | 0.86 X | |||
| Price To Earnings To Growth | 244,930 X | |||
| Target Price | 79.97 | |||
| Number Of Employees | 11.32 K | |||
| Beta | 0.17 | |||
| Market Capitalization | 16.17 B | |||
| Total Asset | 1.24 T | |||
| Retained Earnings | 398.86 B | |||
| Working Capital | 317.36 B | |||
| Current Asset | 467.84 B | |||
| Current Liabilities | 150.48 B | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.95 % | |||
| Net Asset | 1.24 T | |||
| Last Dividend Paid | 160.0 |
About Eisai Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eisai Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eisai using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eisai Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Eisai Pink Sheet
Eisai financial ratios help investors to determine whether Eisai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eisai with respect to the benefits of owning Eisai security.